T32 CA009592/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1997	1
1998	1
1999	1
2000	1
2001	2
2002	4
2003	5
2004	10
2005	8
2006	12
2007	16
2008	31
2009	19
2010	32
2011	26
2012	15
2013	17
2014	24
2015	10
2016	11
2017	8
2018	6
2019	7
2020	6
2021	7
2022	10
2023	14
2024	5

1

Regulation of fatty acid delivery to metastases by tumor endothelium.

Edwards DN, Wang S, Song W, Kim LC, Ngwa VM, Hwang Y, Ess KC, Boothby MR, Chen J. Edwards DN, et al. bioRxiv [Preprint]. 2024 Apr 3:2024.04.02.587724. doi: 10.1101/2024.04.02.587724. bioRxiv. 2024. PMID: 38617241 Free PMC article. Preprint.

2

An in vitro CRISPR screen of cell-free DNA identifies apoptosis as the primary mediator of cell-free DNA release.

Davidson BA, Miranda AX, Reed SC, Bergman RE, Kemp JDJ, Reddy AP, Pantone MV, Fox EK, Dorand RD, Hurley PJ, Croessmann S, Park BH. Davidson BA, et al. Commun Biol. 2024 Apr 10;7(1):441. doi: 10.1038/s42003-024-06129-1. Commun Biol. 2024. PMID: 38600351 Free PMC article.

3

A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists.

Baljon JJ, Kwiatkowski AJ, Pagendarm HM, Stone PT, Kumar A, Bharti V, Schulman JA, Becker KW, Roth EW, Christov PP, Joyce S, Wilson JT. Baljon JJ, et al. ACS Nano. 2024 Mar 5;18(9):6845-6862. doi: 10.1021/acsnano.3c04471. Epub 2024 Feb 22. ACS Nano. 2024. PMID: 38386282 Free PMC article.

4

Polycomb repressor complex 2 suppresses interferon-responsive MHC-II expression in melanoma cells and is associated with anti-PD-1 resistance.

James JL, Taylor BC, Axelrod ML, Sun X, Guerin LN, Gonzalez-Ericsson PI, Wang Y, Sanchez V, Fahey CC, Sanders ME, Xu Y, Hodges E, Johnson DB, Balko JM. James JL, et al. J Immunother Cancer. 2023 Nov 20;11(11):e007736. doi: 10.1136/jitc-2023-007736. J Immunother Cancer. 2023. PMID: 38315170 Free PMC article.

5

Pembrolizumab alters the tumor immune landscape in a patient with dMMR glioblastoma.

Bartkowiak T, Brockman AA, Mobley BC, Harmsen H, Moots P, Merrell R, Johnson DB, Thompson RC, Puduvalli VK, Ihrie RA. Bartkowiak T, et al. medRxiv [Preprint]. 2023 Dec 26:2023.12.08.23299732. doi: 10.1101/2023.12.08.23299732. medRxiv. 2023. PMID: 38234786 Free PMC article. Preprint.

6

Myeloid deletion of talin-1 reduces mucosal macrophages and protects mice from colonic inflammation.

Latour YL, McNamara KM, Allaman MM, Barry DP, Smith TM, Asim M, Williams KJ, Hawkins CV, Jacobse J, Goettel JA, Delgado AG, Piazuelo MB, Washington MK, Gobert AP, Wilson KT. Latour YL, et al. Sci Rep. 2023 Dec 15;13(1):22368. doi: 10.1038/s41598-023-49614-z. Sci Rep. 2023. PMID: 38102166 Free PMC article.

7

Plasma Cell Differentiation, Antibody Quality, and Initial Germinal Center B Cell Population Depend on Glucose Influx Rate.

Brookens SK, Cho SH, Paik Y, Meyer K, Raybuck AL, Park C, Greenwood DL, Rathmell JC, Boothby MR. Brookens SK, et al. J Immunol. 2024 Jan 1;212(1):43-56. doi: 10.4049/jimmunol.2200756. J Immunol. 2024. PMID: 37955416

8

Tumor-Reactive CD8+ T Cells Enter a TCF1+PD-1- Dysfunctional State.

Roetman JJ, Erwin MM, Rudloff MW, Favret NR, Detrés Román CR, Apostolova MKI, Murray KA, Lee TF, Lee YA, Philip M. Roetman JJ, et al. Cancer Immunol Res. 2023 Dec 1;11(12):1630-1641. doi: 10.1158/2326-6066.CIR-22-0939. Cancer Immunol Res. 2023. PMID: 37844197

9

Immune checkpoint inhibitors in bone metastasis: Clinical challenges, toxicities, and mechanisms.

Joseph GJ, Johnson DB, Johnson RW. Joseph GJ, et al. J Bone Oncol. 2023 Sep 30;43:100505. doi: 10.1016/j.jbo.2023.100505. eCollection 2023 Dec. J Bone Oncol. 2023. PMID: 37842554 Free PMC article. Review.

10

NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer.

Taylor BC, Sun X, Gonzalez-Ericsson PI, Sanchez V, Sanders ME, Wescott EC, Opalenik SR, Hanna A, Chou ST, Van Kaer L, Gomez H, Isaacs C, Ballinger TJ, Santa-Maria CA, Shah PD, Dees EC, Lehmann BD, Abramson VG, Pietenpol JA, Balko JM. Taylor BC, et al. Cancer Discov. 2024 Feb 8;14(2):290-307. doi: 10.1158/2159-8290.CD-23-0519. Cancer Discov. 2024. PMID: 37791898 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

280 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

280 results

Results by year